Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Bladder CancerUrinary Tract Infection
Interventions
DEVICE

Irrisept® Antimicrobial Wound Lavage

Irrisept® Antimicrobial Wound Lavage is a single-use, manual, self-contained irrigation device comprised of a 450mL bottle of 0.05% Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water for Irrigation, United States Pharmacopeia (USP) and an applicator (labeled Irriprobe®). The solution is aseptically filled in a Blow-Fill-Seal (BFS) bottle. The CHG acts as a preservative to inhibit microbial growth in the solution.

Trial Locations (1)

10029

RECRUITING

Mount Sinai Hospital, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Irrimax Corporation

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT06689176 - Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion | Biotech Hunter | Biotech Hunter